Center-Authored Papers

Filters: Author is Pepe, Margaret S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Janes H, Longton G, Pepe MS.  2009.  Accommodating Covariates in ROC Analysis.. The Stata journal. 9(1):17-39. Abstract
Janes H, Pepe MS.  2008.  Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting.. American journal of epidemiology. 168(1):89-97. Abstract
Zheng Y, Cai T, Pepe MS.  2013.  Adopting nested case-control quota sampling designs for the evaluation of risk markers.. Lifetime data analysis. 19(4):568-88. Abstract
Janes H, Brown MD, Huang Y, Pepe MS.  2014.  An Approach to Evaluating and Comparing Biomarkers for Patient Treatment Selection.. The international journal of biostatistics. Abstract
Huang Y, Pepe MS.  2010.  Assessing risk prediction models in case-control studies using semiparametric and nonparametric methods.. Statistics in medicine. 29(13):1391-410. Abstract
Janes H, Pepe MS, Gu W.  2008.  Assessing the value of risk predictions by using risk stratification tables.. Annals of internal medicine. 149(10):751-60. Abstract
B
Huang Y, Pepe MS.  2009.  Biomarker evaluation and comparison using the controls as a reference population.. Biostatistics (Oxford, England). 10(2):228-44. Abstract
C
Pepe MS, Janes H.  2011.  Commentary: Reporting standards are needed for evaluations of risk reclassification.. International journal of epidemiology. 40(4):1106-8.
Pepe MS, Feng Z, Longton G, Koopmeiners J.  2009.  Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility.. Statistics in medicine. 28(5):762-79. Abstract
Marks JR, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS.  2015.  Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(2):435-41. Abstract
Morris DE, Pepe MS, Barlow WE.  2010.  Contrasting two frameworks for ROC analysis of ordinal ratings.. Medical decision making : an international journal of the Society for Medical Decision Making. 30(4):484-98. Abstract
D
Janes H, Brown MD, Pepe MS.  2015.  Designing a study to evaluate the benefit of a biomarker for selecting patient treatment.. Statistics in medicine. 34(27):3503-3515. Abstract
Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA, Carney PA, Geller BM, Longton GM, Nelson HD, Oster NV et al..  2017.  The diagnostic challenge of low-grade ductal carcinoma in situ.. European journal of cancer (Oxford, England : 1990). 80:39-47. Abstract
Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson ANA, Nelson HD, Pepe MS, Allison KH, Schnitt SJ et al..  2015.  Diagnostic concordance among pathologists interpreting breast biopsy specimens.. JAMA. 313(11):1122-32. Abstract
Jackson SL, Frederick PD, Pepe MS, Nelson HD, Weaver DL, Allison KH, Carney PA, Geller BM, Tosteson ANA, Onega T et al..  2016.  Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time? Annals of surgical oncology. Abstract
Elmore JG, Pepe MS, Weaver DL.  2015.  Discordant Interpretations of Breast Biopsy Specimens by Pathologists--Reply.. JAMA. 314(1):83-4.
Vickers AJ, Pepe MS.  2014.  Does the Net Reclassification Improvement Help Us Evaluate Models and Markers? Annals of Internal Medicine. 160:136-137. Abstract
E
Pepe MS, Janes H, Li CI, Bossuyt PM, Feng Z, Hilden J.  2016.  Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility? Clinical chemistry. Abstract
Gu W, Pepe MS.  2009.  Estimating the capacity for improvement in risk prediction with a marker.. Biostatistics (Oxford, England). 10(1):172-86. Abstract
Gu W, Pepe MS.  2011.  Estimating the diagnostic likelihood ratio of a continuous marker.. Biostatistics (Oxford, England). 12(1):87-101. Abstract
Pepe MS, Longton G, Janes H.  2009.  Estimation and Comparison of Receiver Operating Characteristic Curves.. The Stata journal. 9(1):1. Abstract
Pepe MS, Zheng Y, Jin Y, Huang Y, Parikh CR, Levy WC.  2008.  Evaluating the ROC performance of markers for future events.. Lifetime data analysis. 14(1):86-113. Abstract
Elmore JG, Tosteson ANA, Pepe MS, Longton GM, Nelson HD, Geller B, Carney PA, Onega T, Allison KH, Jackson SL et al..  2016.  Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.. BMJ (Clinical research ed.). 353:i3069. Abstract
F
Janes H, Pepe MS, Huang Y.  2013.  A Framework for Evaluating Markers Used to Select Patient Treatment.. Medical decision making : an international journal of the Society for Medical Decision Making. Abstract
Janes H, Pepe MS, McShane LM, Sargent DJ, Heagerty PJ.  2015.  The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment.. Journal of the National Cancer Institute. 107(8) Abstract